Key result
NOACs for stroke prevention in NVAF require provider knowledge of indications and risk stratification tools.
Highlights the importance of risk stratification and knowledge of new oral anticoagulants for stroke prevention in nonvalvular atrial fibrillation.
Answers are grounded in this paper and cite their sources.
Requires clinician familiarity with NOAC indications in nonvalvular AF; leaves open prospective evaluation of educational interventions.
Atrial fibrillation is the most common arrhythmia in adults, and the risk for stroke is increased five-fold. Efforts should be made to educate health care providers to understand the importance of using risk stratification tools. New oral anticoagulants are available for thromboembolic stroke prevention, and knowledge of their clinical indications and use is essential.
No takes yet. Share an insight, caveat, or question.
Patrick et al. (2015) studied this question. New oral anticoagulants are available for stroke prevention in nonvalvular atrial fibrillation, making provider knowledge of their clinical indications and risk stratification tools essential.
Synapse has enriched 10 related papers. Consider them for comparative context: